Registration, abstract submission and award deadlines will be announced soon.
21st International Conference on Emerging Frontiers in Cancer Research
Menu
Dr. Jayashree Aiyar photo
India flag

Invited Speaker

Dr. Jayashree Aiyar

Chief Scientific Officer, Syngene International Ltd

Country of work: 🇮🇳 India

Biography

Jayashree has over 30 years of experience as a molecular pharmacologist and has led drug discovery programs in global organizations in the US like AstraZeneca, Merck, Ambrx and Theravance and Jubilant Biosys in India. Jayashree has more than 30 peer-reviewed publications and book chapters to her credit and two issued patents.

Jayashree joined Syngene in 2016 to lead the Discovery Biology function which has grown significantly under her leadership. In her role as Chief Scientific Officer, Jayashree plays a pivotal role in driving our scientific strategy and innovation in R&D,  as well as strengthen academic and industry collaborations, ensuring that Syngene  continues to  lead with cutting-edge solutions for our clients.

Jayashree holds a PhD in Immunology from the All India Institute of Medical Sciences, New Delhi and post-doctoral research at the California Institute of Technology and the University of California at Irvine.

Research Interests

Harnessing the Immune System for Cancer Cell-Therapy

Registration & Fees WhatsApp